Invest1 publisherNot yet confirmed elsewhere3 min readPublished
Oura postpones a $15.6 billion IPO that would have paid selling shareholders 73% of the cash
Oura has postponed an IPO that valued it at up to $15.6 billion, with existing holders selling 73% of the shares on offer. To pay that price, public buyers had to see an AI health platform in a company whose sales still lean on a ring.
The Investor · Invest desk
Drafted by a language model from the sources cited here and checked against its claim ledger before publication. How we use AISend a correction
What happened
- CEO Tom Hale delayed the listing on Sept. 29, after a much-anticipated roadshow, citing uncertainty in the IPO market.
- Oura had proposed selling 50 million shares at $40 to $44 each, about $2.1 billion in gross proceeds at the $42 midpoint.
- At the midpoint the company itself would have received about $567 million, and selling shareholders about $1.53 billion.
- Oura described the move as a postponement and gave no date for a new attempt.
Compiled by The InvestorSomething wrong?How this is made
Why it matters
- contradiction Hale blamed market uncertainty, while Fortune's reporting points to the valuation and a sale built mostly for existing holders, and those explanations call for different fixes.
- exposure Holders who planned to sell 36.5 million shares stay in a private company, with no public price for their stock until Oura tries again.
- cost Oura has to fund its AI and health-platform ambitions without the new capital the offering would have supplied.
The price range implies a share count. A fully diluted value of $15.6 billion at $44 a share works out to roughly 355 million shares [17]. That makes the 50 million shares on offer about 14% of the company [18], and the 13.5 million new ones about 3.8% of the fully diluted count [19]. On the same count, the $40 bottom of the range valued Oura at about $14.2 billion [20]. Even at the top of the range, Oura would have collected about $594 million and the sellers about $1.6 billion [22].
Sellers would have taken about $2.70 for every dollar of new money [21]. Morgan Chittum, reporting for Fortune, cited that structure and a tricky valuation as reasons investors may have paused [15]. "That's a flag for the market," said Kat Siu, a vice president at IPOX [10][9]. "It's signaling that this IPO is not meant for growth." [9]
Siu also set out the valuation case. "If you are viewing Oura as an AI-enabled digital-health platform ... then whatever multiple they are looking for can kind of be justified," she said [6]. "But if you are just looking at them as a pure ring manufacturer, just consumer hardware, then that valuation is pretty hefty." [7] Oura has used its data set and AI tie-ins to argue that it is more than a ring company [16]. According to Siu, its sales still lean heavily toward hardware [8], and it competes with Apple [13]. Allie Garfinkle, who writes Fortune's Term Sheet newsletter and wears the ring, wrote: "I don't use too many of its AI-branded features" [12]. Fortune did not report Oura's revenue or the state of its order book, so the public record does not show what multiple buyers were being asked to pay.
Three readings fit the stop, and each predicts different terms if Oura comes back. If the market was the problem, as Hale said [1], Oura returns at $40 to $44 with the same 13.5 million new shares [2][4]. If the price was the problem, the range comes down. If the structure was the problem, more of the 50 million shares are newly issued and fewer are sold by insiders.
I think price and structure were the same problem. Insiders held 73% of the deal [4], so they would have taken most of any price cut. Each dollar off the range would have cost them $36.5 million, against $13.5 million for the company [23]. Oura said only that it was "postponing" [11]. If it relaunches at the same range and split and the book fills, Hale's explanation was right and mine was wrong.
One case is not enough to set a rule for hardware listings. Garfinkle wrote that the IPO market may be "in suspended animation for a while still" [14]. What happened at Oura is specific: a platform price on a business whose sales lean on hardware, with insiders selling most of the stock, failed to close after a roadshow [1][4][8].
What to watch
- A refiled price range: anything below $40 to $44 would point to price as the obstacle. Hale cited market uncertainty.
- The primary slice: more than 13.5 million newly issued shares in a new filing would mean Oura changed the structure for buyers.
- Whether the next consumer-hardware IPO candidate also leans on shares sold by existing holders after Oura's stop.